Summary:
Seagen has received European Union Marketing Authorization for TUKYSA (tucatinib) a highly selective tyrosine kinase inhibitor (TKI), for HER2+ metastatic breast cancer patients. Currently, Seagen is building its infrastructure in Europe, which includes a group of 6 operating Affiliates located in different countries, that will allow the commercialization of TUKYSA (tucatinib).
Based in our International HQ in Zug (Switzerland), this role will lead projects related to Data and Business Analytics, reporting to the Director of Business Analytics International region. It will work closely with Global, Regions outside of the US, and country affiliates teams including Marketing, Sales, Commercial Excellence, IT and more. The role requires strong analytical skills, communication skills, leadership, and integrative thinking. This is an outstanding opportunity to have an influence on the leadership, development, and success of Seagen as it continues to build its presence internationally.
Responsibilities:
Qualifications:
The candidate should also demonstrate a leadership style that fits within the Seagen culture. The successful candidate will demonstrate the highest integrity and ethical behavior, mutual respect for our people, a true passion for science and in making a difference in patient's lives, works collaboratively within teams, uses resources carefully and can build a great place to work.
Education:
As a leading employer in our industry, Seagen is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. To learn more about Seagen, please visit www.Seagen.com.
#LI-LO1